Meet SmartPlate: the latest gadget hoping to help the health-conscious.
Unless Europe’s governments take action, it will be dealing with an obesity epidemic of vast proportions by 2030.
Alexion said it would buy Synageva for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease.
One of the U.K's most prominent fund managers has joined Bill Gates in backing a small biopharmaceutical firm with a bumper $50 million investment.
Get the best of CNBC in your inbox